Bruker Signs Deal with ImaBiotech to Distribute Quantinetix Software for MALDI MS Imaging | GenomeWeb

NEW YORK (GenomeWeb News) – Bruker said today that it has entered an agreement with Loos, France-based biotech firm ImaBiotech to distribute that company's Quantinetix software for MALDI mass spec imaging.

Quantinetix enables quantification and normalization of molecules identified via MALDI mass spec imaging. The software allows for whole-body distribution analyses in which analytes are imaged and quantified across more than 25 organs. It also offers tools for single organ and targeted applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.